gastrointestinal diseases

Research estimates that 15.6 million people born between 2008 and 2017 worldwide will develop gastric cancer at some point in their lives if current trends continue. In Spain, there would be 58,641 cases, or 1.24% of people in this age group. The team used data on gastric cancer from 185 countries in 2022 combined with mortality projections based on United Nations demographic data. The estimates, published in the journal Nature Medicine, show that 76% of cases could be attributed to Helicobacter pylori, a common bacterium found in the stomach.

An international study has warned of the potential risks of widespread use of faecal microbiota transplantation without taking into account the region of the intestine where the transferred microbes arrive. The experiment, conducted on mice and human tissue samples, showed that the microbes from the transplant—mostly anaerobic microbes from the colon—colonised the small intestine, persisted there for months and modified that new environment, causing changes in the host's metabolism. According to the authors, whose study is published in the journal Cell, this may have long-lasting and unforeseen consequences, as well as imbalances in the intestinal ecosystem of patients.

According to the results of a phase 2 trial, an oral norovirus vaccine generated a strong mucosal immune response and even reduced viral shedding in vaccinated volunteers. Signs of the vaccine's efficacy support its potential to address the lack of safe and reliable vaccines against this virus, which is a major cause of gastrointestinal infections worldwide. The results were published today in the journal Science Translational Medicine.

The Human Cell Atlas, an international research consortium, publishes biological data from different cell types in the human body in a series of articles in Nature and other journals in its family. One of the articles integrates single-cell RNA sequencing datasets from the gastrointestinal tract of healthy people and others with different diseases. It describes inflammation-induced changes in stem cells that alter mucosal tissue architecture and promote increased inflammation, a concept that can be applied to other tissues and diseases.

People who do not have coeliac disease or wheat allergy sometimes reduce their gluten intake because they believe it is the cause of their gastrointestinal symptoms. A study has found that there may be a nocebo effect - negative anticipation of a substance or treatment, the opposite of the placebo effect - on gluten sensitivity in these people, so that the mere thought of ingesting gluten causes more symptoms in those who believe they are sensitive to it. The results are published in the journal The Lancet Gastroenterology & Hepatology.

Certain intestinal issues, such as constipation, difficulty swallowing, and irritable bowel syndrome, could be early warning signs of Parkinson's disease, according to a study published in the journal Gut. The study compared tens of thousands of patients from a network of medical records in the United States.

The European Medicines Agency (EMA) safety committee (PRAC) has recommended a change to the information on codeine-ibuprofen combination medicines to include "a warning about serious harm, including death, especially when taken for prolonged periods at higher than recommended doses". The PRAC reviewed several cases of renal, gastrointestinal and metabolic toxicity that had been reported in association with cases of abuse and dependence on these drugs.